ArticleBioscience reports2022

INK4 cyclin-dependent kinase inhibitors as potential prognostic biomarkers and therapeutic targets in hepatocellular carcinoma.

Hui Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.